Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Analyzing public perception toward COVID-19 vaccines in Indonesia

International Journal of Public Health Science · Vol. 13 No. 1 (2024) · hlm. 428–437

DOI
10.11591/ijphs.v13i1.23134
ISSN
2620-4126, 2252-8806
Terbit
2024-03-01
Penerbit
Intelektual Pustaka Media Utama
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-nc/4.0

Abstrak

The research is prompted by the dearth of studies addressing public perceptions of various COVID-19 vaccines in Indonesia using extensive datasets spanning and a wide timeframe. This study examined public perception toward COVID-19 vaccines in Indonesia using a dataset of tweets. We further detect whether there are any changes in sentiment toward each type of vaccine. The five most commonly used vaccines in Indonesia (AstraZeneca, Moderna, Pfizer, Sinopharm, and Sinovac) were analyzed for sentiment using a lexicon-based method: Valence Aware Dictionary and Sentiment Reasoner (VADER), with changes in sentiment detected using Pruned Exact Linear Time (PELT). The 280,826 tweets collected between 2021 and 2022, 39% were positive, 18% were negative, and 43% were neutral. While Indonesian citizens generally responded positively and neutrally to each vaccine, with Sinopharm and Pfizer receiving the highest sentiment scores and AstraZeneca receiving the lowest, some change points in sentiment were associated with real-world events. Jakarta had the highest number of tweets (22%), while Maluku had the highest sentiment score (0.498). A significant positive correlation was also found between the total number of tweets and two variables: new cases of COVID-19 (r=0.9, p=0.001) and total new deaths caused by COVID-19 (r=0.8, p=0.008). Overall, the discussion of COVID-19 vaccines is still ongoing, and Indonesian citizens tend to respond neutrally and positively regardless of location or time.

Jaringan kolaborasi para penulis

18 penulis · 33 tautan kepenulisan bersama · 9 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • University of Indonesia
  • Institut Teknologi Bacharuddin Jusuf Habibie
  • Taylor's University
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Nuzulul Khairu NissaUniversity of Indonesia2
Nicholas PangestuUniversity of Indonesia2
Jatmiko Budi BaskoroUniversity of Indonesia1
Muhammad Rizki SyazaliUniversity of Indonesia1
Naradhipa BharyUniversity of Indonesia1
Jafar AbdurrohmanUniversity of Indonesia1
Fariz Wahyuzan DwitilasUniversity of Indonesia1
Eka Qadri NurantiInstitut Teknologi Bacharuddin Jusuf Habibie1
Husna Sarirah HusinTaylor's University1
Muhammad Okky IbrohimUniversity of Indonesia1
Chandra LesmanaAfiliasi tidak diketahui1
Indra BudiAfiliasi tidak diketahui1
Piawai Said UmbaraUniversity of Indonesia1
Ika AlfinaUniversity of Indonesia1
Gabriel EnriqueUniversity of Indonesia1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://ijphs.iaescore.com/index.php/IJPHS/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Analyzing public perception toward COVID-19 vaccines in Indonesia</dc:title>
	<dc:creator>Rizqiyah, Putri</dc:creator>
	<dc:creator>Yulianti, Evi</dc:creator>
	<dc:creator>Jiwanggi, Meganingrum Arista</dc:creator>
	<dc:description xml:lang="en-US">The research is prompted by the dearth of studies addressing public perceptions of various COVID-19 vaccines in Indonesia using extensive datasets spanning and a wide timeframe. This study examined public perception toward COVID-19 vaccines in Indonesia using a dataset of tweets. We further detect whether there are any changes in sentiment toward each type of vaccine. The five most commonly used vaccines in Indonesia (AstraZeneca, Moderna, Pfizer, Sinopharm, and Sinovac) were analyzed for sentiment using a lexicon-based method: Valence Aware Dictionary and Sentiment Reasoner (VADER), with changes in sentiment detected using Pruned Exact Linear Time (PELT). The 280,826 tweets collected between 2021 and 2022, 39% were positive, 18% were negative, and 43% were neutral. While Indonesian citizens generally responded positively and neutrally to each vaccine, with Sinopharm and Pfizer receiving the highest sentiment scores and AstraZeneca receiving the lowest, some change points in sentiment were associated with real-world events. Jakarta had the highest number of tweets (22%), while Maluku had the highest sentiment score (0.498). A significant positive correlation was also found between the total number of tweets and two variables: new cases of COVID-19 (r=0.9, p=0.001) and total new deaths caused by COVID-19 (r=0.8, p=0.008). Overall, the discussion of COVID-19 vaccines is still ongoing, and Indonesian citizens tend to respond neutrally and positively regardless of location or time.</dc:description>
	<dc:publisher xml:lang="en-US">Intelektual Pustaka Media Utama</dc:publisher>
	<dc:contributor xml:lang="en-US">Evi Yulianti, Universitas Indonesia</dc:contributor>
	<dc:contributor xml:lang="en-US">Meganingrum Arista Jiwanggi, Universitas Indonesia</dc:contributor>
	<dc:date>2024-03-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US"></dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://ijphs.iaescore.com/index.php/IJPHS/article/view/23134</dc:identifier>
	<dc:identifier>10.11591/ijphs.v13i1.23134</dc:identifier>
	<dc:source xml:lang="en-US">International Journal of Public Health Science (IJPHS); Vol 13, No 1: March 2024; 428-437</dc:source>
	<dc:source>2620-4126</dc:source>
	<dc:source>2252-8806</dc:source>
	<dc:source>10.11591/ijphs.v13i1</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://ijphs.iaescore.com/index.php/IJPHS/article/view/23134/14297</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2023 Institute of Advanced Engineering and Science</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>